Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orion Integrated Biosciences is a biotechnology company specializing in genomic analysis and bioinformatics to address challenges in infectious diseases and biodefense. The company leverages its proprietary Genomic Signature Discovery (GSD) platform to identify unique genomic signatures for the development of precision diagnostics, vaccines, and therapeutics. Orion's work primarily involves high-consequence pathogens and emerging infectious diseases, frequently collaborating with government agencies like the Department of Defense and the National Institutes of Health. Their technology integrates diverse biological data to accelerate the discovery of biomarkers and drug targets for both human and agricultural health. Headquartered in New York with research facilities in Kansas, Orion is a key player in the development of countermeasures for global health security.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orion Integrated Biosciences.